Press Releases

Press Releases

Pharma Major Lupin Limited (Lupin) has entered into a definitive agreement to acquire privately held GAVIS Pharmaceuticals LLC and Novel Laboratories Inc. (GAVIS), subject to certain closing conditions, in a transaction valued at USD 880 million, cash free and debt free. The transaction has been unanimously approved by the Boards…

Thursday, Jul 23, 2015
Press Releases

Clinical Trails Middle East 2015 23-26 November 2015 Dubai http://www.clinicaltrials-middleeast.com/ IBC Asia’s  Clinical Trials Middle East will focus on regulatory frameworks and various clinical pathways in the Middle East region. It will discuss challenges with conducting trials in the respective regions and strategies to overcome them. A key focus will…

Thursday, Jul 23, 2015
Press Releases

Pharma Manufacturing Middle East 2015 23-26 November 2015 Dubai http://www.pharmamanufacturing-mena.com/ A rapid increase in population, particularly an expanding middle class demanding better care has attracted global pharmaceutical companies into the Middle East's pharmaceutical market. The region is now competing with Asia and Latin America countries in terms of production growth…

Press Releases

The 22st edition of the International Specialized Exhibition ”Apteka-2015” will take place on 7-10 December 2015 in CEC “Expocentre” in Moscow. Traditionally, “APTEKA” exhibition will be held within the Russian Healthcare Week, demonstrating its significant contribution to the development of the pharmaceutical industry. “APTEKA” exhibition has obtained the status of…

Press Releases

Polydex Pharmaceuticals Limited announced that its Annual General Meeting is to be held at 10:00 am, local time, on August 28, 2015, at the principal offices of the Company located at 421 Comstock Road, Toronto, Ontario, Canada, M1L 2H5. The Company also announced the inaugural use of e-voting and encourages…

Press Releases

Heron Therapeutics, Inc., a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, today announced that it has resubmitted its New Drug Application (NDA) for SUSTOL® (granisetron) Injection, extended release, for the prevention of acute and delayed chemotherapy-induced nausea and…

Press Releases

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, was informed today by its licensee, GtreeBNT Co. Ltd. (Gtree), headquartered in Gyeonggi-do, South Korea, that it has received approval from the Ministry of Food and Drug Safety (MFDS) in Korea to conduct a Phase…

Press Releases

Amerita, a wholly owned subsidiary of PharMerica and specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital, announced today that it has been awarded Specialty Pharmacy Accreditation from URAC, the independent, nonprofit leader in the accreditation of health and managed care…

Press Releases

The U.S. Food and Drug Administration today authorized use of the first prosthesis marketed in the U.S. for adults who have amputations above the knee and who have rehabilitation problems with, or cannot use, a conventional socket prosthesis. The Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) device instead uses…

Press Releases

Resilient Systems (formerly Co3 Systems), the leading Incident Response Platform (IRP) provider, has today announced that Teva Pharmaceutical Industries Ltd., a global pharmaceutical company, has selected the Resilient Systems IRP to manage response to cybersecurity incidents. Following a detailed scope of requirements and analysis of multiple vendors, Teva selected Resilient…